Eskens FALM - Search Results

1

Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives.

Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Herrera-Martínez AD, et al. Among authors: eskens falm. Drugs. 2019 Jan;79(1):21-42. doi: 10.1007/s40265-018-1033-0. Drugs. 2019. PMID: 30560479 Free PMC article. Review.

2

New targets and innovative strategies in cancer treatment: a short course for clinicians. 7-8 February 2003, Monte Carlo, Monaco.

Eskens F. Eskens F. IDrugs. 2003 Mar;6(3):207-10. IDrugs. 2003. PMID: 12838991 No abstract available.

3

Clinical trial design for target specific anticancer agents.

Hoekstra R, Verweij J, Eskens FA. Hoekstra R, et al. Invest New Drugs. 2003 May;21(2):243-50. doi: 10.1023/a:1023581731443. Invest New Drugs. 2003. PMID: 12889742 Review.

4

Long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based study.

Poleé IN, Hermans BCM, van der Zwan JM, Bouwense SAW, Dercksen MW, Eskens FALM, Havekes B, Hofland J, Kerkhofs TMA, Klümpen HJ, Latten-Jansen LM, Speel EM, Verburg FA, Walenkamp AME, Geurts SME, de Vos-Geelen J. Poleé IN, et al. Among authors: eskens falm. Eur J Cancer. 2022 Sep;172:252-263. doi: 10.1016/j.ejca.2022.06.003. Epub 2022 Jul 6. Eur J Cancer. 2022. PMID: 35803176 Free article.

5

Systemic treatment in hepatocellular carcinoma; 'A small step for man...'.

Witjes CD, Verhoef C, Verheul HM, Eskens FA. Witjes CD, et al. Neth J Med. 2009 Mar;67(3):86-90. Neth J Med. 2009. PMID: 19307678 Free article. Review.

6

Moving molecular targeted drug therapy towards personalized medicine: issues related to clinical trial design.

Verweij J, de Jonge M, Eskens F, Sleijfer S. Verweij J, et al. Mol Oncol. 2012 Apr;6(2):196-203. doi: 10.1016/j.molonc.2012.01.009. Epub 2012 Feb 16. Mol Oncol. 2012. PMID: 22386481 Free PMC article. Review.

7

FOLFIRINOX and radiotherapy for locally advanced pancreatic cancer: A cohort study.

Suker M, Nuyttens JJ, Groot Koerkamp B, Eskens FALM, van Eijck CHJ. Suker M, et al. Among authors: eskens falm. J Surg Oncol. 2018 Nov;118(6):1021-1026. doi: 10.1002/jso.25233. Epub 2018 Sep 27. J Surg Oncol. 2018. PMID: 30259526 Free PMC article.

8

Efficacy and safety of FOLFIRINOX as salvage treatment in advanced biliary tract cancer: an open-label, single arm, phase 2 trial.

Belkouz A, de Vos-Geelen J, Mathôt RAA, Eskens FALM, van Gulik TM, van Oijen MGH, Punt CJA, Wilmink JW, Klümpen HJ. Belkouz A, et al. Among authors: eskens falm. Br J Cancer. 2020 Mar;122(5):634-639. doi: 10.1038/s41416-019-0698-9. Epub 2020 Jan 10. Br J Cancer. 2020. PMID: 31919404 Free PMC article. Clinical Trial.

9

First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study.

van Meerten E, Eskens FA, van Gameren EC, Doorn L, van der Gaast A. van Meerten E, et al. Br J Cancer. 2007 May 7;96(9):1348-52. doi: 10.1038/sj.bjc.6603750. Epub 2007 Apr 17. Br J Cancer. 2007. PMID: 17437008 Free PMC article. Clinical Trial.

10

The spliceosome as target for anticancer treatment.

van Alphen RJ, Wiemer EA, Burger H, Eskens FA. van Alphen RJ, et al. Br J Cancer. 2009 Jan 27;100(2):228-32. doi: 10.1038/sj.bjc.6604801. Epub 2008 Nov 25. Br J Cancer. 2009. PMID: 19034274 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters